Behold.ai wins highest accolade in life sciences with greatest potential impact on global human health at the Prix Galien International in Rome
On 20th June 2024 at a spectacular international award ceremony in Rome, Italy, celebrating excellence of innovations in the life science sector, Behold.ai have won the Prix Galien International award for Best Digital Health Solution.
Bruno Cohen, Chairman of The Galien Foundation. “We extend our utmost gratitude to our 2024 International Prix Galien and Prix Galien Italy winners who have proven that continued perseverance, dedication, and innovation for the future of healthcare is paving the way forward for us all.”
Behold.ai’s red dot® V2 Clinical Analysis Software can autonomously rule out normal patients who present for a chest x-ray in 7 seconds, and identify priority suspected lung cancer cases in combination with the Radiologist.
It is a proven solution to speed up diagnosis and with a global shortage of Radiologists, the technology has shown to standardise the speed and accuracy of lung cancer diagnosis in the non-screening population delivering the opportunity of health care equality on a global scale.
“We are honoured to host the Prix Galien Italy and International Prix Galien in tandem, bringing together the most forward-thinking innovators across the life sciences here in Italy, and across the world,” said Pr. Pier Luigi Canonico, Chair of the Prix Galien Italy and International Prix Galien Awards Committee. “It is thrilling to welcome those who have excelled in the pursuit of scientific advancement to the global stage, and we look forward to seeing their continued success as Prix Galien alumni.”
Simon Rasalingham, CEO and Chairman of Behold.ai, “this award further demonstrates, in conjunction with our UK Prix Galien award in 2022, that we are serious force for saving time, money and lives on a global stage.
The NHS is in a critical state and needs assistance from great British companies such as Behold.ai, which is supported by NHS Consultant Radiologists.”
The technology is deployed in the UK can save 22,000 lives each year and add diagnostic capacity back into the NHS which is equivalent to 233 Consultant Radiologists using one line of AI-enabled code.
The award ceremony in Rome, Italy attended by global leaders of life science organisations with innovations providing the greatest potential impact on human health, the technology has the potential to save millions of lives each on a global scale, whilst adding vital diagnostic AI capacity to health care systems crumbling after the global pandemic.
Behold.ai
Behold.ai utilise cutting-edge science to pioneer new forms of diagnostic medicine; this innovative approach to healthcare is a step change in the treatment and prevention of lung cancer and brain related illnesses, delivering benefits to patients across the NHS today.
Behold.ai provides artificial intelligence, through its regulated red dot® platform, to radiology departments. Behold.ai’s technology augments the expertise of radiologists to enable them to report with greater clinical accuracy, faster and more safely than they could before. This revolutionary combination helps save time, money and lives.
The behold.ai algorithm has been developed using more than 150,000 example images, all of which have been reviewed and reported by highly experienced UK consultant radiology clinicians in order to shape accurate decision making. The red dot® prioritisation platform is capable of sorting images into normal and abnormal categories in 7 seconds post image acquisition straight back into hospital systems.
For Public Relations, please contact:
External Relations, Email: info@behold.ai
About the Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.
The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa. The Honorary Founding President of the Galien Foundation was the Professor Elie Wiesel, 1986 Peace Nobel Laureate.
The Prix Galien was created in 1970 by Roland Mehl in honour of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research. Following are some notable Nobel Laureates current or past Jury Members of Prix Galien worldwide.
- Pr Günter BLOBEL, Honorary Professor, University of Frankfurt Lasker Award
- Pr Linda BUCK, Ph.D., Fred Hutchinson Cancer Research Center Professor, and Affiliate Professor of Physiology and Biophysics, University of Washington
- Pr Richard AXEL, M.D, Co-director, the Kavli Institute for Brain Science , Columbia University Medical Center, New York.
- Pr Michael S. BROWN, M.D., Professor of Molecular Genetics and Internal Medicine, UT Southwestern Medical Center at Dallas
- Pr Walter GILBERT, Ph.D., Carl M. Loeb University Professor Emeritus, Harvard University
- Pr Joseph GOLDSTEIN, M.D., Professor of Molecular Genetics and Internal Medicine, UT Southwestern Medical Center at Dallas
- Pr Paul GREENGARD, Ph.D., Vincent Astor Professor of Molecular and Cellular Neuroscience, Rockefeller University
- Pr François JACOB, Académie Française, Academy of Sciences; Honorary Professeur, Collège de France and Institut Pasteur
- Pr Eric R. KANDEL, M.D., Professor of Physiology and Cellular Biophysics, Columbia University
- Pr Joshua LEDERBERG, M.D., Ph.D., Professor Emeritus, Laboratory of Molecular Genetics and Informatics, Rockefeller University
- Pr Stanley B. PRUSINER, M.D. Professor of Neurology. Director, Institute for Neurodegenerative Diseases. University of California, San Francisco
- Pr Bengt SAMUELSSON, M.D., Ph.D., Professor Emeritus, Karolinska Institutet, Nobel Foundation
- Pr Phillip A. SHARP, Ph.D., Professor of Biology and member of the Koch Institute, Chair of the advisory board of the MIT Jameel Clinic
For more information, visit www.galienfoundation.org.
Follow the Foundation on social media:
https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/
Media Contact:
Kara Bradley
Finn Partners
Kara.Bradley@finnpartners.com
+1 646-213-7243
